ELV Elevance Health
fair · 61
Owner-earnings value$524.00
Price$416.54
Margin of safety
+25.8%
Quality gate · 61/100
Median ROIC11.0%
Net debt / EBITDA2.6x
FCF conversion92%
Share count / yr-2.5%
Profitable years4/4
Moat & management
Owner-earnings inputs
| Owner earnings (TTM) | 5.30B |
| Owner-earnings yield | 5.9% |
| Free-cash-flow yield | 7.0% |
| Growth used (normalized) | 8.3% |
| Market-implied growth (reverse DCF) | 2.8% |
| Terminal growth | 3.0% |
| Discount rate (hurdle) | 9.0% |
Projected owner earnings
| Yr | Owner earnings | Growth | PV |
|---|---|---|---|
| 1 | 5.74B | 8.3% | 5.27B |
| 2 | 6.19B | 7.7% | 5.21B |
| 3 | 6.63B | 7.2% | 5.12B |
| 4 | 7.07B | 6.6% | 5.01B |
| 5 | 7.49B | 6.0% | 4.87B |
| 6 | 7.89B | 5.4% | 4.70B |
| 7 | 8.27B | 4.8% | 4.52B |
| 8 | 8.61B | 4.2% | 4.32B |
| 9 | 8.92B | 3.6% | 4.11B |
| 10 | 9.19B | 3.0% | 3.88B |
Recent news
score · 8 articles
- Should You Buy Elevance Health Stock For The Margin It Lost?
- UnitedHealth Reshapes Florida WellMed Operations With TPG Deal
- Elevance Health Inc's Dividend Analysis
- Why Is UNH Stock Trading At A Premium With The Slowest Growth?
- UnitedHealth Slips 3% as TPG Buys Into Florida WellMed Clinics Ahead of Guidance Reaffirmation
- 2 Reasons to Watch ELV and 1 to Stay Cautious
- Insurers Have Already Told Wall Street Which Advantage Plans Die on December 31. Members Are the Last to Know, and the Letter Isn’t Due Until October 2.
- Elevance Health (ELV) Stock Still Looks Undervalued Despite Its 37% Run
⚠ maintenance capex ≈ min(capex, D&A), capped at FCF · Price pays for ~3%/yr owner-earnings growth over 10y (reverse DCF); model credits 8%.